Presentation Cell Therapy 2013 REVIVE: Retrograde Bone Marrow-Derived Cells for Dilated Cardiomyopathy Presenter: Amit N. Patel January 22, 2013
News Industry News Heart Metabolics Receives Funding for U.S. Clinical Development of Heart Failure Drug January 02, 2013
News Daily News ‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC Caitlin E. Cox December 26, 2012
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012
Presentation TCT 2012 Long-term Outcomes of Alcohol Septal Ablation Presenter: Richard Bach October 25, 2012
Presentation TCT 2012 Dynamic Obstruction: Mechanisms and Implications for Treatment Presenter: Carey Kimmelstiel October 25, 2012
Presentation TCT 2012 Alcohol Septal Ablation: The Procedure Step by Step Presenter: Christopher Nielsen October 25, 2012
Presentation TCT 2012 The Future? Radiofrequency Catheter Septal Ablation for HCM Presenter: Rod Stables October 25, 2012
Presentation TCT 2012 Inpatient and Outpatient Management After Alcohol Septal Ablation Presenter: Michael Fifer October 25, 2012
Presentation TCT 2012 Hypothermia Treatment in a Patient with Stress-Induced Cardiomyopathy and Cardiogenic Shock Presenter: Petur Petursson October 25, 2012
Presentation TCT 2012 Historical Perspective on Alcohol Septal Ablation Presenter: Ulrich Sigwart October 25, 2012
Presentation TCT 2012 HCM Management: What Do the Guidelines Say? Presenter: Bernard Gersh October 25, 2012
Presentation TCT 2012 HCM and Sudden Cardiac Death: When to Consider an ICD Presenter: Bernard Gersh October 25, 2012
Presentation TCT 2012 Epidemiology and Natural History of HCM Presenter: John Douglas Jr October 25, 2012
Presentation TCT 2012 Complications: How to Avoid, How to Treat Presenter: Srihari Naidu October 25, 2012
Presentation TCT 2012 Case Selection for Alcohol Septal Ablation Presenter: Sherif Nagueh October 25, 2012